Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Goldman Sachs has maintained its Buy rating for Incyte (NASDAQ:INCY) but lowered its price target from $114.00 to $98.00. Incyte's shares are currently trading down 1.43% at $53.59 per share. A move to $98.00 would represent an 82.87% increase from the current share price.
November 02, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Goldman Sachs maintains its Buy rating for Incyte but lowers its price target. This could potentially lead to an increase in the stock's price if the market reacts positively to the maintained Buy rating.
Goldman Sachs' maintained Buy rating indicates a positive outlook for Incyte, which could encourage investors to buy the stock, potentially driving up its price. However, the lowered price target might reflect a more conservative estimate of the stock's future performance.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100